Your browser doesn't support javascript.
loading
The WHO 2013 oral glucose tolerance test: The utility of isolated glucose measurements - A retrospective cohort study.
Rademaker, D; de Groot, E C M; van den Akker, E S; Franx, A; van Rijn, B B; DeVries, J H; Siegelaar, S E; Painter, R C.
Afiliación
  • Rademaker D; Amsterdam UMC Location University of Amsterdam, Department of Obstetrics and Gynecology, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands. Electronic address: d.rademaker@amsterdamumc.nl.
  • de Groot ECM; Amsterdam UMC Location University of Amsterdam, Department of Obstetrics and Gynecology, Meibergdreef 9, Amsterdam, the Netherlands.
  • van den Akker ES; Department of Obstetrics and Gynecology, OLVG, Amsterdam, the Netherlands.
  • Franx A; Department of Obstetrics and Gynecology, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands.
  • van Rijn BB; Department of Obstetrics and Gynecology, Máxima Medical Center, Veldhoven, the Netherlands; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
  • DeVries JH; Department of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.
  • Siegelaar SE; Department of Endocrinology and Metabolism, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, the Netherlands.
  • Painter RC; Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Obstetrics and Gynecology, Boelelaan 1117, Amsterdam, the Netherlands.
Eur J Obstet Gynecol Reprod Biol ; 296: 371-375, 2024 May.
Article en En | MEDLINE | ID: mdl-38552506
ABSTRACT

OBJECTIVE:

The WHO 2013 guidelines recommend screening for gestational diabetes mellitus (GDM) by 3-point oral glucose tolerance test (OGTT). The objective of this retrospective cohort study was to evaluate GDM diagnosed by an isolated high glucose. STUDY

DESIGN:

We included pregnant women deemed at risk for GDM were offered GDM screening. We examined the records of 1939 consecutively screened pregnancies at two teaching hospitals in Amsterdam during 2016-2020. Using the WHO 2013 diagnostic criteria, we calculated the proportion of GDM cases diagnosed by isolated abnormal glucose values.

RESULTS:

Among those screened in our high risk cohort, GDM incidence was 31.5%. Of the GDM diagnoses, 57.0% were based on an isolated fasting glucose value, 30.9% based on multiple raised glucose measurements, 7.4% on an isolated raised 2-hour glucose and 4.7% on an isolated raised 1-hour glucose. For 1-hour glucose, the number needed to screen was 67 persons for one additional GDM case.

CONCLUSION:

The 1-hour glucose in the 3 point OGTT, as suggested by the WHO 2013 guidelines for GDM, contributes only small numbers of GDM cases and a high number needed to screen (67 for 1 additional case in a selective high risk GDM screening strategy), and is likely even less effective in universally screened populations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal / 2_salud_sexual_reprodutiva Asunto principal: Glucemia / Diabetes Gestacional Límite: Female / Humans / Pregnancy Idioma: En Revista: Eur J Obstet Gynecol Reprod Biol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal / 2_salud_sexual_reprodutiva Asunto principal: Glucemia / Diabetes Gestacional Límite: Female / Humans / Pregnancy Idioma: En Revista: Eur J Obstet Gynecol Reprod Biol Año: 2024 Tipo del documento: Article
...